Herpes Simplex Infections Pipeline Review, H1 2015
M2 - Fri Jun 12, 4:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ttlczd/herpes_simplex) has announced the addition of the "Herpes Simplex Infections - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Herpes Simplex Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Herpes Simplex Infections and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - 3-V Biosciences, Inc. - Adamis Pharmaceuticals Corporation - Admedus Ltd - Agenus, Inc. - AiCuris GmbH & Co. KG - AlphaVax, Inc. - Astellas Pharma Inc. - Beech Tree Labs, Inc. - BioApex, s.r.o. - CEL-SCI Corporation - Chimerix, Inc. - Colby Pharmaceutical Company - Epiphany Biosciences, Inc. - Foamix Pharmaceuticals Ltd. - Genocea Biosciences, Inc. - GenVec, Inc. - Immune Design Corp. - Immunovaccine, Inc. - Kala Pharmaceuticals, Inc. - Mymetics Corporation - NanoBio Corporation - NanoViricides, Inc. - NovaBay Pharmaceuticals, Inc. - Onxeo SA - Oryzon Genomics S.A. - Osel Inc. - PaxVax - Peregrine Pharmaceuticals, Inc. - Profectus BioSciences, Inc. - Romark Laboratories, L.C. - Sanofi - Sanofi Pasteur SA - Spider Biotech - Starpharma Holdings Limited - Vaccibody AS For more information visit http://www.researchandmarkets.com/research/tt...es_simplex
IMDZ: 24.04 (+3.00), CVM: 0.67 (+0.04), FOMX: 11.18 (+0.22), ADMP: 4.08 (+0.08), GNCA: 14.39 (+0.15), NNVC: 1.56 (-0.04), CMRX: 46.90 (+1.08)
Leading 100 Medical Technology Companies of Asia 2015
M2 - Mon Mar 23, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3bxckf/asia_medical) has announced the addition of the "Asia Medical Technology 100 - An Industry Report" report to their offering. One key trend upcoming in this market is the emergence of user-friendly technologies, which reduce the number of hospital visits and help in the close monitoring of a patient's physiological parameters. The emergence of user-friendly technologies permits the frequent evaluation of these parameters without any assistance from a physician. Asia's medical technology industry is projected to experience top line growth at 2-5 times the rate of developed markets. Global medtech industry is expected to hit US$228 billion by 2015, driven largely by an aging population and climbing societal risk factors such as cardiovascular disease and diabetes. Coupled with longer life expectancy and rising affluence in Asia, this presents companies with immense opportunities to expand the reach of their medical products and business networks in the region. Our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of Asian companies in the medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies of Asia - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among Asian medical technology companies - International presence of Asian medical technology companies - R&D activities by Asian medical technology companies Report Includes Companies Engaged in: - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products Companies Mentioned (Partial List) - A&T Corporation (Japan) - Accuray Medical Equipment (India) Private Limited (India) - Admedus Ltd (Australia) - Analytica Limited (Australia) - Angels Health Private Limited (India) - Ashva Technologies Pvt. Ltd. (India) - Asiamedic Limited (Singapore) - Attune Technologies Private Limited (India) - Axsys Health Tech Limited (India) - Azure Healthcare Ltd (Australia) - Beijing Bohui Innovation Tech (China) - Biodenta Corp (Taiwan) - Bionime Corporation (Taiwan) - Bluechiip Limited (Australia) - Brain Resource Ltd (Australia) - Carefusion Development Private Limited (India) - Cogstate Ltd. (Australia) - Compumedics Limited (Australia) - CoWealth Medical Holding Co., Ltd. (China) - CU Medical Systems Inc (Korea (South)) For more information visit http://www.researchandmarkets.com/research/3b...ia_medical